论文部分内容阅读
文适(糠酸氟替卡松鼻用喷雾剂)是葛兰素史克公司于2003年新上市的治疗变应性鼻炎(AR)的药物。作为最新的糖皮质激素化合物——糠酸氟替卡松具有目前已知的糖皮质激素化合物中最强受体亲和力,能够强效改善AR患者的打喷嚏、鼻痒、流涕、鼻塞四大鼻部症状,更一致的改善眼痒、眼红、流泪三大眼部症状,显著提高AR患者的生活质量。其人性化的给药装置,侧边驱动,短小喷嘴,均匀细腻喷雾,患者满意度更高。相信文适在中国的上市,能够带给中国AR患者新的用药选择,帮助鼻炎患者摆脱鼻眼七大症状困扰,真正微笑起来。
Wen Sifu (fluticasone furoate nasal spray) is GSK’s new drug in 2003 for the treatment of allergic rhinitis (AR). As the latest glucocorticoid compound, fluticasone furoate has the strongest receptor affinity among currently known glucocorticoid compounds and can effectively improve the symptoms of the four nasal symptoms of sneezing, nasal itching, runny nose and stuffy nose in AR patients , More consistent improvement of itchy eyes, jealous, tearing eyes three eye symptoms, significantly improve the quality of life of AR patients. Its user-friendly dosing device, side-driven, short nozzle, uniform and delicate spray, patient satisfaction higher. Believe that the text suitable for the Chinese market, can bring new drug options for AR patients in China, to help patients get rid of rhinitis seven symptoms of nose trouble, really smile together.